Karyotype service for Human cells
Request a quote
Our human karyotype service provides G-banding analysis of a minimum of 20* metaphase spreads per sample, delivering a detailed report with the karyotype designation in ISCN nomenclature and at least one publication-quality image. We can scale up the analysis to meet your requirements, for example 30, 40, 50, and 60 metaphase spreads. This service is widely used as essential quality control for iPSC and embryonic stem cell (ESC) lines, where chromosomal abnormalities can accumulate during culture and compromise experimental results. We accept both fixed samples (BSL1 and BSL2, shipped at room temperature) and live cell cultures (BSL1, UK and Europe only). Standard turnaround is 7–10 business days, with an express option available for time-sensitive projects. For a full overview of our karyotyping capabilities, including mouse and other species, see our karyotype analysis service page.
*Note that this does not apply to highly complex unstable cancer karyotypes.
This service currently has good availability. Please contact us at [email protected] to schedule sample arrival.
Protocols and workflow
Biosafety level
We are able to process live BSL1 samples. Fixed samples (we will provide you with the protocol) can be BSL1 or BSL2 and do not require evidence of pathogen screening.
Fixed cell requirements
Please strictly adhere to the following requirements for fixed samples:
- Samples are shipped at room temperature
- Fixed samples are stored in a 2 mL screw cap tube
- Samples are minimum 500 µL in volume
- Please do not send any samples without booking in advance
If you have any questions, please contact us by email at [email protected]. We will respond within one business day.
Product documents
Example of a normal human sample report.pdf Example of an abnormal human sample report.pdf
Citations
See the full updated list on Google Scholar
Burkard M, Bengtson Nash S, Gambaro G, Whitworth D, and Schirmer K. Lifetime extension of humpback whale skin fibroblasts and their response to lipopolysaccharide (LPS) and a mixture of polychlorinated biphenyls (Aroclor). (2019). Cell Biol Toxicol.
Schöndorf DC, Elschami M, Schieck M, Ercan-Herbst E, Weber C, Riesinger Y, Kalman S, Steinemann D, and Ehrnhoefer DE. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease. (2018). Stem Cell Research Jan;34:101351.
Joshi PS, Modur V, Cheng J, Robinson K and Rao K. Characterization of immortalized human mammary epithelial cell line HMEC 2.6. (2017). Tumour biology Oct;39(10):1010428317724283.
Tidball AM, Dang LT, Glenn TW, Kilbane EG, Klarr DJ, Margolis JL, Uhler MD, and Parent JM. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing. (2017). Stem Cell Reports 9(3): 725-731.
Ludtmann MHR, Arber C, Bartolome F, de Vicente M, Preza E, Carro E, Houlden H, Gandhi S, Wray S, and Abramov AY. Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. (2017). Journal of Biological Chemistry 292(21): 8907-8917.
Zhang Y, Schmid B, Nielsen TT, Nielsen JE, Clausen C, Hyttel P, Holst B, and Freude KK. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. (2016). Stem Cell Research 17(1): 148-150.
Chen H, Aksoy I, Gonnot F, Osteil P, Aubry M, Hamela C, Rognard C, Hochard A, Voisin S, Fontaine E, et al. Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. (2015). Nature Communications 6: 7095.
